Safety and immunogenicity of intradermal fractional dose administration of the mRNA-1273 vaccine: a proof-of-concept study

Author(s):: Roozen, G.V.T. (0000-0002-3979-4616); Prins, M.L.M. (0000-0001-9788-425X); Binnendijk, R. van; Hartog, G. den; Kuiper, V.P.; Prins, C.; Janse, J.J.; Kruithof, A.C.; Feltkamp, M.C.W. (0000-0001-5993-9846); Kuijer, M.; Rosendaal, F.R. (0000-0003-2558-7496); Roestenberg, M. (0000-0002-5052-2830); Visser, L.G. (0000-0002-3600-9782); Roukens, A.H.E. (0000-0002-1397-0992)

Published: 2022
Publication type: Article / Letter to editor

Date issued: 2022-10-25
Language: English
Publisher: AMER COLL PHYSICIANS
Is part of: Annals of Internal Medicine (2022), Vol. 175, no. 12, p. 1771-1774
hdl: 1887/3514839
doi: 10.7326/M22-2089
URL: https://www.acpjournals.org/doi/10.7326/M22-2089